{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:22:57Z","timestamp":1774524177934,"version":"3.50.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["402440\/2021-8"],"award-info":[{"award-number":["402440\/2021-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["19\/2551-0001662-0"],"award-info":[{"award-number":["19\/2551-0001662-0"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia \u2013 Excitotoxicidade e Neuroprote\u00e7\u00e3o","award":["465671\/2014\u20134"],"award-info":[{"award-number":["465671\/2014\u20134"]}]},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia \u2013 Sa\u00fade Cerebral","award":["406020\/2022-1"],"award-info":[{"award-number":["406020\/2022-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s12035-023-03718-9","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T06:01:56Z","timestamp":1698818516000},"page":"2496-2513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In Vivo Intracerebral Administration of \u03b1-Ketoisocaproic Acid to Neonate Rats Disrupts Brain Redox Homeostasis and Promotes Neuronal Death, Glial Reactivity, and Myelination Injury"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3060-7711","authenticated-orcid":false,"given":"\u00c2ngela Beatris","family":"Zemnia\u00e7ak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5814-6369","authenticated-orcid":false,"given":"Rafael Teixeira","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2868-3504","authenticated-orcid":false,"given":"Camila Vieira","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4154-138X","authenticated-orcid":false,"given":"S\u00e2mela","family":"de Azevedo Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4247-6457","authenticated-orcid":false,"given":"Tailine Quevedo","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2358-6695","authenticated-orcid":false,"given":"Ediandra Tissot","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7964-8923","authenticated-orcid":false,"given":"Guilhian","family":"Leipnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6372-1807","authenticated-orcid":false,"given":"Moacir","family":"Wajner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6512-0714","authenticated-orcid":false,"given":"Alexandre Umpierrez","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"key":"3718_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1036\/Ommbid.400","volume-title":"The online metabolic and molecular bases of inherited disease","author":"DT Chuang","year":"2019","unstructured":"Chuang DT, Shih VE, Wynn RM (2019) Maple syrup urine disease (branched-chain ketoaciduria). In: Valle DL, Antonarakis S, Ballabio A, Beaudet AL, Mitchell GA (eds) The online metabolic and molecular bases of inherited disease. McGraw-Hill, New York City (NY), pp. 1\u201374. https:\/\/doi.org\/10.1036\/Ommbid.400"},{"key":"3718_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/J.YMGME.2020.01.006","volume":"129","author":"KA Strauss","year":"2020","unstructured":"Strauss KA, Carson VJ, Soltys K et al (2020) Branched-chain \u03b1-ketoacid dehydrogenase deficiency (maple syrup urine disease): treatment, biomarkers, and outcomes. Mol Genet Metab 129:193\u2013206. https:\/\/doi.org\/10.1016\/J.YMGME.2020.01.006","journal-title":"Mol Genet Metab"},{"key":"3718_CR3","doi-asserted-by":"publisher","first-page":"117483","DOI":"10.1016\/J.CCA.2023.117483","volume":"548","author":"T Chen","year":"2023","unstructured":"Chen T, Lu D, Xu F et al (2023) Newborn screening of maple syrup urine disease and the effect of early diagnosis. Clin Chim Acta 548:117483. https:\/\/doi.org\/10.1016\/J.CCA.2023.117483","journal-title":"Clin Chim Acta"},{"key":"3718_CR4","doi-asserted-by":"publisher","first-page":"1132364","DOI":"10.3389\/FGENE.2023.1132364","volume":"14","author":"L Li","year":"2023","unstructured":"Li L, Mao X, Yang N et al (2023) Identification of gene mutations in six Chinese patients with maple syrup urine disease. Front Genet 14:1132364. https:\/\/doi.org\/10.3389\/FGENE.2023.1132364","journal-title":"Front Genet"},{"key":"3718_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.47391\/JPMA.1341","volume":"71","author":"A Allahwala","year":"2021","unstructured":"Allahwala A, Ahmed S, Afroze B (2021) Maple syrup urine disease: magnetic resonance imaging findings in three patients. J Pak Med Assoc 71:1\u201311. https:\/\/doi.org\/10.47391\/JPMA.1341","journal-title":"J Pak Med Assoc"},{"key":"3718_CR6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5152\/DIR.2017.16466","volume":"23","author":"A Cheng","year":"2017","unstructured":"Cheng A, Han L, Feng Y et al (2017) MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases. Diagn Interv Radiol 23:398\u2013402. https:\/\/doi.org\/10.5152\/DIR.2017.16466","journal-title":"Diagn Interv Radiol"},{"key":"3718_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/JPN.JPN_38_17","volume":"13","author":"AS Kathait","year":"2018","unstructured":"Kathait AS, Puac P, Castillo M (2018) Imaging findings in maple syrup urine disease: a case report. J Pediatr Neurosci 13:103\u2013105. https:\/\/doi.org\/10.4103\/JPN.JPN_38_17","journal-title":"J Pediatr Neurosci"},{"key":"3718_CR8","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1172\/JCI67217","volume":"123","author":"ER Muelly","year":"2013","unstructured":"Muelly ER, Moore GJ, Bunce SC et al (2013) Biochemical correlates of neuropsychiatric illness in maple syrup urine disease. J Clin Invest 123:1809\u20131820. https:\/\/doi.org\/10.1172\/JCI67217","journal-title":"J Clin Invest"},{"key":"3718_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/J.YMGME.2004.01.016","volume":"82","author":"S Sch\u00f6nberger","year":"2004","unstructured":"Sch\u00f6nberger S, Schweiger B, Schwahn B et al (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69\u201375. https:\/\/doi.org\/10.1016\/J.YMGME.2004.01.016","journal-title":"Mol Genet Metab"},{"key":"3718_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pbb.2003.10.013","volume":"77","author":"VDC Vasques","year":"2004","unstructured":"Vasques VDC, De Boer MA, Diligenti F et al (2004) Intrahippocampal administration of the \u03b1-keto acids accumulating in maple syrup urine disease provokes learning deficits in rats. Pharmacol Biochem Behav 77:183\u2013190. https:\/\/doi.org\/10.1016\/j.pbb.2003.10.013","journal-title":"Pharmacol Biochem Behav"},{"key":"3718_CR11","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/S11011-017-0035-Z","volume":"32","author":"L Taschetto","year":"2017","unstructured":"Taschetto L, Scaini G, Zapelini HG et al (2017) Acute and long-term effects of intracerebroventricular administration of \u03b1-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors. Metab Brain Dis 32:1507\u20131518. https:\/\/doi.org\/10.1007\/S11011-017-0035-Z","journal-title":"Metab Brain Dis"},{"key":"3718_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/S11011-015-9768-8","volume":"31","author":"MSW Wisniewski","year":"2016","unstructured":"Wisniewski MSW, Carvalho-Silva M, Gomes LM et al (2016) Intracerebroventricular administration of \u03b1-ketoisocaproic acid decreases brain-derived neurotrophic factor and nerve growth factor levels in brain of young rats. Metab Brain Dis 31:377\u2013383. https:\/\/doi.org\/10.1007\/S11011-015-9768-8","journal-title":"Metab Brain Dis"},{"key":"3718_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/S11011-020-00626-Y","volume":"36","author":"HR Farias","year":"2021","unstructured":"Farias HR, Gabriel JR, Cecconi ML et al (2021) The metabolic effect of \u03b1-ketoisocaproic acid: in vivo and in vitro studies. Metab Brain Dis 36:185\u2013192. https:\/\/doi.org\/10.1007\/S11011-020-00626-Y","journal-title":"Metab Brain Dis"},{"key":"3718_CR14","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/S11011-023-01193-8","volume":"38","author":"F Rabelo","year":"2023","unstructured":"Rabelo F, Lemos ID, Dal To\u00e9 CP et al (2023) Acute effects of intracerebroventricular administration of \u03b1-ketoisocaproic acid in young rats on inflammatory parameters. Metab Brain Dis 38:1573\u20131579. https:\/\/doi.org\/10.1007\/S11011-023-01193-8","journal-title":"Metab Brain Dis"},{"key":"3718_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11011-005-4152-8","volume":"20","author":"R Bridi","year":"2005","unstructured":"Bridi R, Braun CA, Zorzi GK et al (2005) \u03b1-Keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab Brain Dis 20:155\u2013167. https:\/\/doi.org\/10.1007\/s11011-005-4152-8","journal-title":"Metab Brain Dis"},{"key":"3718_CR16","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/J.NEUINT.2006.05.007","volume":"49","author":"C Funchal","year":"2006","unstructured":"Funchal C, Latini A, Jacques-Silva MC et al (2006) Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain \u03b1-keto acids accumulating in maple syrup urine disease. Neurochem Int 49:640\u2013650. https:\/\/doi.org\/10.1016\/J.NEUINT.2006.05.007","journal-title":"Neurochem Int"},{"key":"3718_CR17","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/J.1471-4159.1973.TB00298.X","volume":"20","author":"MS Patel","year":"1973","unstructured":"Patel MS, Auerbach VH, Grover WD, Wilbur DO (1973) Effect of the branched-chain \u03b1-keto acids on pyruvate metabolism by homogenates of human brain. J Neurochem 20:1793\u20131796. https:\/\/doi.org\/10.1111\/J.1471-4159.1973.TB00298.X","journal-title":"J Neurochem"},{"key":"3718_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/S11064-007-9423-9","volume":"33","author":"CA Ribeiro","year":"2008","unstructured":"Ribeiro CA, Sgaravatti \u00c2M, Rosa RB et al (2008) Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease. Neurochem Res 33:114\u2013124. https:\/\/doi.org\/10.1007\/S11064-007-9423-9","journal-title":"Neurochem Res"},{"key":"3718_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/J.BRAINRES.2010.02.018","volume":"1324","author":"AU Amaral","year":"2010","unstructured":"Amaral AU, Leipnitz G, Fernandes CG et al (2010) \u03b1-Ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain. Brain Res 1324:75\u201384. https:\/\/doi.org\/10.1016\/J.BRAINRES.2010.02.018","journal-title":"Brain Res"},{"key":"3718_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/J.BBADIS.2003.09.010","volume":"1639","author":"AM Sgaravatti","year":"2003","unstructured":"Sgaravatti AM, Rosa RB, Schuck PF et al (2003) Inhibition of brain energy metabolism by the \u03b1-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta 1639:232\u2013238. https:\/\/doi.org\/10.1016\/J.BBADIS.2003.09.010","journal-title":"Biochim Biophys Acta"},{"key":"3718_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0736-5748(03)00074-1","volume":"21","author":"R Bridi","year":"2003","unstructured":"Bridi R, Araldi J, Sgarbi MB et al (2003) Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int J Dev Neurosci 21:327\u2013332. https:\/\/doi.org\/10.1016\/S0736-5748(03)00074-1","journal-title":"Int J Dev Neurosci"},{"key":"3718_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/S11011-011-9238-X","volume":"26","author":"C Mescka","year":"2011","unstructured":"Mescka C, Moraes T, Rosa A et al (2011) In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease. Metab Brain Dis 26:21\u201328. https:\/\/doi.org\/10.1007\/S11011-011-9238-X","journal-title":"Metab Brain Dis"},{"key":"3718_CR23","doi-asserted-by":"publisher","first-page":"6007","DOI":"10.1007\/S12035-015-9500-Z","volume":"53","author":"CP Mescka","year":"2016","unstructured":"Mescka CP, Rosa AP, Schirmbeck G et al (2016) L-Carnitine prevents oxidative stress in the brains of rats subjected to a chemically induced chronic model of MSUD. Mol Neurobiol 53:6007\u20136017. https:\/\/doi.org\/10.1007\/S12035-015-9500-Z","journal-title":"Mol Neurobiol"},{"key":"3718_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/J.YMGME.2012.04.009","volume":"106","author":"G Scaini","year":"2012","unstructured":"Scaini G, Jeremias IC, Morais MOS et al (2012) DNA damage in an animal model of maple syrup urine disease. Mol Genet Metab 106:169\u2013174. https:\/\/doi.org\/10.1016\/J.YMGME.2012.04.009","journal-title":"Mol Genet Metab"},{"key":"3718_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/A:1021974517837","volume":"18","author":"C Pilla","year":"2003","unstructured":"Pilla C, De Oliveira Cardozo RF, Dutra-Filho CS et al (2003) Effect of leucine administration on creatine kinase activity in rat brain. Metab Brain Dis 18:17\u201325. https:\/\/doi.org\/10.1023\/A:1021974517837","journal-title":"Metab Brain Dis"},{"key":"3718_CR26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1023\/A:1022876130038","volume":"28","author":"C Pilla","year":"2003","unstructured":"Pilla C, De Oliveira Cardozo RF, Dutra-Filho CS et al (2003) Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro. Neurochem Res 28:675\u2013679. https:\/\/doi.org\/10.1023\/A:1022876130038","journal-title":"Neurochem Res"},{"key":"3718_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/S11011-006-9030-5","volume":"21","author":"AG Barschak","year":"2006","unstructured":"Barschak AG, Sitta A, Deon M et al (2006) Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease. Metab Brain Dis 21:279\u2013286. https:\/\/doi.org\/10.1007\/S11011-006-9030-5","journal-title":"Metab Brain Dis"},{"key":"3718_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/J.IJDEVNEU.2015.02.003","volume":"42","author":"G Guerreiro","year":"2015","unstructured":"Guerreiro G, Mescka CP, Sitta A et al (2015) Urinary biomarkers of oxidative damage in maple syrup urine disease: the L-carnitine role. Int J Dev Neurosci 42:10\u201314. https:\/\/doi.org\/10.1016\/J.IJDEVNEU.2015.02.003","journal-title":"Int J Dev Neurosci"},{"key":"3718_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/J.IJDEVNEU.2012.10.109","volume":"31","author":"CP Mescka","year":"2013","unstructured":"Mescka CP, Wayhs CAY, Vanzin CS et al (2013) Protein and lipid damage in maple syrup urine disease patients: L-carnitine effect. Int J Dev Neurosci 31:21\u201324. https:\/\/doi.org\/10.1016\/J.IJDEVNEU.2012.10.109","journal-title":"Int J Dev Neurosci"},{"key":"3718_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/J.YMGME.2009.06.007","volume":"98","author":"PJ Mc Guire","year":"2009","unstructured":"Mc Guire PJ, Parikh A, Diaz GA (2009) Profiling of oxidative stress in patients with inborn errors of metabolism. Mol Genet Metab 98:173\u2013180. https:\/\/doi.org\/10.1016\/J.YMGME.2009.06.007","journal-title":"Mol Genet Metab"},{"key":"3718_CR31","doi-asserted-by":"publisher","first-page":"e20831","DOI":"10.1371\/JOURNAL.PONE.0020831","volume":"6","author":"S Olivera-Bravo","year":"2011","unstructured":"Olivera-Bravo S, Fern\u00e1ndez A, Sarlab\u00f3s MN et al (2011) Neonatal astrocyte damage is sufficient to trigger progressive striatal degeneration in a rat model of glutaric acidemia-I. PLoS One 6:e20831. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0020831","journal-title":"PLoS One"},{"key":"3718_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/J.NEUROSCIENCE.2021.07.024","volume":"471","author":"RT Ribeiro","year":"2021","unstructured":"Ribeiro RT, Seminotti B, Zanatta \u00c2 et al (2021) Neuronal death, glial reactivity, microglia activation, oxidative stress and bioenergetics impairment caused by intracerebroventricular administration of D-2-hydroxyglutaric acid to neonatal rats. Neuroscience 471:115\u2013132. https:\/\/doi.org\/10.1016\/J.NEUROSCIENCE.2021.07.024","journal-title":"Neuroscience"},{"key":"3718_CR33","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1007\/S12035-018-1275-6","volume":"56","author":"B Seminotti","year":"2019","unstructured":"Seminotti B, Zanatta \u00c2, Ribeiro RT et al (2019) Disruption of brain redox homeostasis, microglia activation and neuronal damage induced by intracerebroventricular administration of s-adenosylmethionine to developing rats. Mol Neurobiol 56:2760\u20132773. https:\/\/doi.org\/10.1007\/S12035-018-1275-6","journal-title":"Mol Neurobiol"},{"key":"3718_CR34","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1007\/S12035-015-9493-7","volume":"53","author":"AP Moura","year":"2016","unstructured":"Moura AP, Parmeggiani B, Grings M et al (2016) Intracerebral glycine administration impairs energy and redox homeostasis and induces glial reactivity in cerebral cortex of newborn rats. Mol Neurobiol 53:5864\u20135875. https:\/\/doi.org\/10.1007\/S12035-015-9493-7","journal-title":"Mol Neurobiol"},{"key":"3718_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/S12640-018-9874-6","volume":"33","author":"RT Ribeiro","year":"2018","unstructured":"Ribeiro RT, Zanatta \u00c2, Amaral AU et al (2018) Experimental evidence that in vivo intracerebral administration of L-2-hydroxyglutaric acid to neonatal rats provokes disruption of redox status and histopathological abnormalities in the brain. Neurotox Res 33:681\u2013692. https:\/\/doi.org\/10.1007\/S12640-018-9874-6","journal-title":"Neurotox Res"},{"key":"3718_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1021\/TX00026A012","volume":"5","author":"CP LeBel","year":"1992","unstructured":"LeBel CP, Ischiropoulos H, Bondy SC (1992) Evaluation of the probe 2\u2019,7\u2019-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5:227\u2013231. https:\/\/doi.org\/10.1021\/TX00026A012","journal-title":"Chem Res Toxicol"},{"key":"3718_CR37","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/CLINCHEM\/44.3.679","volume":"44","author":"JA Navarro-Gonz\u00e1lvez","year":"1998","unstructured":"Navarro-Gonz\u00e1lvez JA, Garc\u00eda-Benayas C, Arenas J (1998) Semiautomated measurement of nitrate in biological fluids. Clin Chem 44:679\u2013681. https:\/\/doi.org\/10.1093\/CLINCHEM\/44.3.679","journal-title":"Clin Chem"},{"key":"3718_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1385\/0-89603-472-0:107","volume":"108","author":"K Yagi","year":"1998","unstructured":"Yagi K (1998) Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol Biol 108:107\u2013110. https:\/\/doi.org\/10.1385\/0-89603-472-0:107","journal-title":"Methods Mol Biol"},{"key":"3718_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","volume":"233","author":"AZ Reznick","year":"1994","unstructured":"Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357\u2013363. https:\/\/doi.org\/10.1016\/S0076-6879(94)33041-7","journal-title":"Methods Enzymol"},{"key":"3718_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1385\/0-89603-472-0:347","volume":"108","author":"RW Browne","year":"1998","unstructured":"Browne RW, Armstrong D (1998) Reduced glutathione and glutathione disulfide. Methods Mol Biol 108:347\u2013352. https:\/\/doi.org\/10.1385\/0-89603-472-0:347","journal-title":"Methods Mol Biol"},{"key":"3718_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0076-6879(81)77046-0","volume":"77","author":"A Wendel","year":"1981","unstructured":"Wendel A (1981) Glutathione peroxidase. Methods Enzymol 77:325\u2013333. https:\/\/doi.org\/10.1016\/S0076-6879(81)77046-0","journal-title":"Methods Enzymol"},{"key":"3718_CR42","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0076-6879(85)13062-4","volume":"113","author":"I Carlberg","year":"1985","unstructured":"Carlberg I, Mannervik B (1985) [59] Glutathione reductase. Methods Enzymol 113:484\u2013490. https:\/\/doi.org\/10.1016\/S0076-6879(85)13062-4","journal-title":"Methods Enzymol"},{"key":"3718_CR43","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0014-5793(85)80613-X","volume":"184","author":"SL Marklund","year":"1985","unstructured":"Marklund SL (1985) Product of extracellular-superoxide dismutase catalysis. FEBS Lett 184:237\u2013239. https:\/\/doi.org\/10.1016\/0014-5793(85)80613-X","journal-title":"FEBS Lett"},{"key":"3718_CR44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275. https:\/\/doi.org\/10.1016\/S0021-9258(19)52451-6","journal-title":"J Biol Chem"},{"key":"3718_CR45","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1152\/PHYSREV.00011.2005","volume":"86","author":"SW Ryter","year":"2006","unstructured":"Ryter SW, Alam J, Choi AMK (2006) Heme oxygenase-1\/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86:583\u2013650. https:\/\/doi.org\/10.1152\/PHYSREV.00011.2005","journal-title":"Physiol Rev"},{"key":"3718_CR46","doi-asserted-by":"publisher","first-page":"105360","DOI":"10.1016\/J.NEUINT.2022.105360","volume":"157","author":"AU Amaral","year":"2022","unstructured":"Amaral AU, Wajner M (2022) Pathophysiology of maple syrup urine disease: focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain \u03b1-keto acids. Neurochem Int 157:105360. https:\/\/doi.org\/10.1016\/J.NEUINT.2022.105360","journal-title":"Neurochem Int"},{"key":"3718_CR47","first-page":"1","volume-title":"GeneReviews\u00ae [Internet]","author":"KA Strauss","year":"2020","unstructured":"Strauss KA, Puffenberger EG, Carson VJ (2020) Maple syrup urine disease. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Mirzaa G, Amemiya A (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle (WA), pp. 1\u201333"},{"key":"3718_CR48","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/S11011-015-9686-9","volume":"30","author":"CP Mescka","year":"2015","unstructured":"Mescka CP, Guerreiro G, Donida B et al (2015) Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation. Metab Brain Dis 30:1167\u20131174. https:\/\/doi.org\/10.1007\/S11011-015-9686-9","journal-title":"Metab Brain Dis"},{"key":"3718_CR49","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1007\/S12035-016-0116-8","volume":"54","author":"G Scaini","year":"2016","unstructured":"Scaini G, Tonon T, de Souza CFM et al (2016) Serum markers of neurodegeneration in maple syrup urine disease. MolNeurobiol 54:5709\u20135719. https:\/\/doi.org\/10.1007\/S12035-016-0116-8","journal-title":"MolNeurobiol"},{"key":"3718_CR50","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/S10545-018-0188-X","volume":"41","author":"G Scaini","year":"2018","unstructured":"Scaini G, Tonon T, Moura de Souza CF et al (2018) Evaluation of plasma biomarkers of inflammation in patients with maple syrup urine disease. J Inherit Metab Dis 41:631\u2013640. https:\/\/doi.org\/10.1007\/S10545-018-0188-X","journal-title":"J Inherit Metab Dis"},{"key":"3718_CR51","doi-asserted-by":"publisher","first-page":"12079","DOI":"10.1073\/PNAS.96.21.12079","volume":"96","author":"RJ Boado","year":"1999","unstructured":"Boado RJ, Li JY, Nagaya M et al (1999) Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci U S A 96:12079\u201312084. https:\/\/doi.org\/10.1073\/PNAS.96.21.12079","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3718_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3940(01)01810-9","volume":"306","author":"DM Killian","year":"2001","unstructured":"Killian DM, Chikhale PJ (2001) Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature. Neurosci Lett 306:1\u20134. https:\/\/doi.org\/10.1016\/S0304-3940(01)01810-9","journal-title":"Neurosci Lett"},{"key":"3718_CR53","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/S11064-017-2261-5","volume":"42","author":"JE Sperringer","year":"2017","unstructured":"Sperringer JE, Addington A, Hutson SM (2017) Branched-chain amino acids and brain metabolism. Neurochem Res 42:1697\u20131709. https:\/\/doi.org\/10.1007\/S11064-017-2261-5","journal-title":"Neurochem Res"},{"key":"3718_CR54","doi-asserted-by":"publisher","first-page":"360438","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Med Cell Longev 2014:360438. https:\/\/doi.org\/10.1155\/2014\/360438","journal-title":"Oxidative Med Cell Longev"},{"key":"3718_CR55","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/J.BBRC.2016.10.086","volume":"482","author":"MM Gaschler","year":"2017","unstructured":"Gaschler MM, Stockwell BR (2017) Lipid peroxidation in cell death. Biochem Biophys Res Commun 482:419\u2013425. https:\/\/doi.org\/10.1016\/J.BBRC.2016.10.086","journal-title":"Biochem Biophys Res Commun"},{"key":"3718_CR56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0009-8981(03)00003-2","volume":"329","author":"I Dalle-Donne","year":"2003","unstructured":"Dalle-Donne I, Rossi R, Giustarini D et al (2003) Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329:23\u201338. https:\/\/doi.org\/10.1016\/S0009-8981(03)00003-2","journal-title":"Clin Chim Acta"},{"key":"3718_CR57","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0076-6879(94)33040-9","volume":"233","author":"RL Levine","year":"1994","unstructured":"Levine RL, Williams JA, Stadtman EP, Shacter E (1994) [37] Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233:346\u2013357. https:\/\/doi.org\/10.1016\/S0076-6879(94)33040-9","journal-title":"Methods Enzymol"},{"key":"3718_CR58","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/ANTIOX8040082","volume":"8","author":"DH Kwon","year":"2019","unstructured":"Kwon DH, Cha HJ, Lee H et al (2019) Protective effect of glutathione against oxidative stress-induced cytotoxicity in RAW 264.7 macrophages through activating the nuclear factor erythroid 2-related factor-2\/heme oxygenase-1 pathway. Antioxidants 8:82. https:\/\/doi.org\/10.3390\/ANTIOX8040082","journal-title":"Antioxidants"},{"key":"3718_CR59","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/J.BCP.2018.02.010","volume":"153","author":"V Vijayan","year":"2018","unstructured":"Vijayan V, Wagener FADTG, Immenschuh S (2018) The macrophage heme-heme oxygenase-1 system and its role in inflammation. Biochem Pharmacol 153:159\u2013167. https:\/\/doi.org\/10.1016\/J.BCP.2018.02.010","journal-title":"Biochem Pharmacol"},{"key":"3718_CR60","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.2174\/1381612824666180717155953","volume":"24","author":"IL Szabo","year":"2018","unstructured":"Szabo IL, Kenyeres A, Szegedi A, Szollosi AG (2018) Heme oxygenase and the skin in health and disease. Curr Pharm Des 24:2303\u20132310. https:\/\/doi.org\/10.2174\/1381612824666180717155953","journal-title":"Curr Pharm Des"},{"key":"3718_CR61","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/S11064-008-9602-3","volume":"33","author":"SAS Pope","year":"2008","unstructured":"Pope SAS, Milton R, Heales SJR (2008) Astrocytes protect against copper-catalysed loss of extracellular glutathione. Neurochem Res 33:1410\u20131418. https:\/\/doi.org\/10.1007\/S11064-008-9602-3","journal-title":"Neurochem Res"},{"key":"3718_CR62","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1046\/J.1471-4159.2002.01216.X","volume":"83","author":"VC Stewart","year":"2002","unstructured":"Stewart VC, Stone R, Gegg ME et al (2002) Preservation of extracellular glutathione by an astrocyte derived factor with properties comparable to extracellular superoxide dismutase. J Neurochem 83:984\u2013991. https:\/\/doi.org\/10.1046\/J.1471-4159.2002.01216.X","journal-title":"J Neurochem"},{"key":"3718_CR63","doi-asserted-by":"publisher","unstructured":"Halliwell B, Gutteridge JMC (2015) Antioxidant defenses synthesized in vivo. Free Radic Biol Med 77\u2013152. https:\/\/doi.org\/10.1093\/ACPROF:OSO\/9780198717478.003.0003","DOI":"10.1093\/ACPROF:OSO\/9780198717478.003.0003"},{"key":"3718_CR64","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/J.AOHEP.2019.04.005","volume":"18","author":"JP Arab","year":"2019","unstructured":"Arab JP, Roblero JP, Altamirano J et al (2019) Alcohol-related liver disease: clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Ann Hepatol 18:518\u2013535. https:\/\/doi.org\/10.1016\/J.AOHEP.2019.04.005","journal-title":"Ann Hepatol"},{"key":"3718_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15376516.2022.2069530","volume":"33","author":"M Angelovski","year":"2023","unstructured":"Angelovski M, Hadzi-Petrushev N, Mitrokhin V et al (2023) Myocardial infarction and oxidative damage in animal models: objective and expectations from the application of cysteine derivatives. Toxicol Mech Methods 33:1\u201317. https:\/\/doi.org\/10.1080\/15376516.2022.2069530","journal-title":"Toxicol Mech Methods"},{"key":"3718_CR66","doi-asserted-by":"publisher","first-page":"106941","DOI":"10.1016\/J.CCT.2022.106941","volume":"122","author":"VA Schoeps","year":"2022","unstructured":"Schoeps VA, Graves JS, Stern WA et al (2022) N-Acetyl cysteine as a neuroprotective agent in progressive multiple sclerosis (NACPMS) trial: study protocol for a randomized, double-blind, placebo-controlled add-on phase 2 trial. Contemp Clin Trials 122:106941. https:\/\/doi.org\/10.1016\/J.CCT.2022.106941","journal-title":"Contemp Clin Trials"},{"key":"3718_CR67","doi-asserted-by":"publisher","first-page":"8582","DOI":"10.26355\/EURREV_202211_30395","volume":"26","author":"P Santus","year":"2022","unstructured":"Santus P, Danzo F, Zuffi A et al (2022) Oxidative stress and viral infections: rationale, experiences, and perspectives on N-acetylcysteine. Eur Rev Med Pharmacol Sci 26:8582\u20138590. https:\/\/doi.org\/10.26355\/EURREV_202211_30395","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3718_CR68","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/S12035-014-8705-X","volume":"50","author":"G Morris","year":"2014","unstructured":"Morris G, Anderson G, Dean O et al (2014) The glutathione system: a new drug target in neuroimmune disorders. Mol Neurobiol 50:1059\u20131084. https:\/\/doi.org\/10.1007\/S12035-014-8705-X","journal-title":"Mol Neurobiol"},{"key":"3718_CR69","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S1734-1140(09)70153-7","volume":"61","author":"N Pawlas","year":"2009","unstructured":"Pawlas N, Nierwi\u0144ska K, Stolecka A et al (2009) Effects of N-acetylcysteine and ebselen on arachidonic acid release from astrocytes and neurons cultured in normoxic or simulated ischemic conditions. Pharmacol Rep 61:941\u2013946. https:\/\/doi.org\/10.1016\/S1734-1140(09)70153-7","journal-title":"Pharmacol Rep"},{"key":"3718_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/J.1600-079X.2003.00092.X","volume":"36","author":"C Rodriguez","year":"2004","unstructured":"Rodriguez C, Mayo JC, Sainz RM et al (2004) Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 36:1\u20139. https:\/\/doi.org\/10.1046\/J.1600-079X.2003.00092.X","journal-title":"J Pineal Res"},{"key":"3718_CR71","first-page":"46","volume":"6","author":"S Malhotra","year":"2004","unstructured":"Malhotra S, Sawhney G, Pandhi P (2004) The therapeutic potential of melatonin: a review of the science. Medscape Gen Med 6:46","journal-title":"Medscape Gen Med"},{"key":"3718_CR72","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2174\/1570159X14666161228122115","volume":"15","author":"S Tordjman","year":"2017","unstructured":"Tordjman S, Chokron S, Delorme R et al (2017) Melatonin: pharmacology, functions and therapeutic benefits. Curr Neuropharmacol 15:434\u2013443. https:\/\/doi.org\/10.2174\/1570159X14666161228122115","journal-title":"Curr Neuropharmacol"},{"key":"3718_CR73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/J.1600-079X.2008.00614.X","volume":"46","author":"M Schaefer","year":"2009","unstructured":"Schaefer M, Hardeland R (2009) The melatonin metabolite N1-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger. J Pineal Res 46:49\u201352. https:\/\/doi.org\/10.1111\/J.1600-079X.2008.00614.X","journal-title":"J Pineal Res"},{"key":"3718_CR74","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/BF02253360","volume":"7","author":"RJ Reiter","year":"2000","unstructured":"Reiter RJ, Tan DX, Osuna C, Gitto E (2000) Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 7:444\u2013458. https:\/\/doi.org\/10.1007\/BF02253360","journal-title":"J Biomed Sci"},{"key":"3718_CR75","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/JPI.12360","volume":"61","author":"RJ Reiter","year":"2016","unstructured":"Reiter RJ, Mayo JC, Tan DX et al (2016) Melatonin as an antioxidant: under promises but over delivers. J Pineal Res 61:253\u2013278. https:\/\/doi.org\/10.1111\/JPI.12360","journal-title":"J Pineal Res"},{"key":"3718_CR76","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/J.1600-079X.2010.00747.X","volume":"48","author":"JB Hoppe","year":"2010","unstructured":"Hoppe JB, Frozza RL, Horn AP et al (2010) Amyloid-\u03b2 neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3\u03b2, tau and neuroinflammation. J Pineal Res 48:230\u2013238. https:\/\/doi.org\/10.1111\/J.1600-079X.2010.00747.X","journal-title":"J Pineal Res"},{"key":"3718_CR77","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/JPI.12267","volume":"59","author":"LC Manchester","year":"2015","unstructured":"Manchester LC, Coto-Montes A, Boga JA et al (2015) Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res 59:403\u2013419. https:\/\/doi.org\/10.1111\/JPI.12267","journal-title":"J Pineal Res"},{"key":"3718_CR78","doi-asserted-by":"publisher","first-page":"18886","DOI":"10.3390\/MOLECULES201018886","volume":"20","author":"DX Tan","year":"2015","unstructured":"Tan DX, Manchester LC, Esteban-Zubero E et al (2015) Melatonin as a potent and inducible endogenous antioxidant: synthesis and metabolism. Molecules 20:18886\u201318906. https:\/\/doi.org\/10.3390\/MOLECULES201018886","journal-title":"Molecules"},{"key":"3718_CR79","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/S11481-016-9702-9","volume":"11","author":"J Wen","year":"2016","unstructured":"Wen J, Ariyannur PS, Ribeiro R et al (2016) Efficacy of N-acetylserotonin and melatonin in the EAE model of multiple sclerosis. J NeuroImmune Pharmacol 11:763\u2013773. https:\/\/doi.org\/10.1007\/S11481-016-9702-9","journal-title":"J NeuroImmune Pharmacol"},{"key":"3718_CR80","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/S11481-018-9824-3","volume":"14","author":"T Muhammad","year":"2019","unstructured":"Muhammad T, Ali T, Ikram M et al (2019) Melatonin rescue oxidative stress-mediated neuroinflammation\/neurodegeneration and memory impairment in scopolamine-induced amnesia mice model. J NeuroImmune Pharmacol 14:278\u2013294. https:\/\/doi.org\/10.1007\/S11481-018-9824-3","journal-title":"J NeuroImmune Pharmacol"},{"key":"3718_CR81","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/CNS.12588","volume":"23","author":"SA Shah","year":"2017","unstructured":"Shah SA, Khan M, Jo MH et al (2017) Melatonin stimulates the SIRT1\/Nrf2 signaling pathway counteracting lipopolysaccharide (LPS)-induced oxidative stress to rescue postnatal rat brain. CNS Neurosci Ther 23:33\u201344. https:\/\/doi.org\/10.1111\/CNS.12588","journal-title":"CNS Neurosci Ther"},{"key":"3718_CR82","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/BIOF.1934","volume":"49","author":"F Yarmohammadi","year":"2023","unstructured":"Yarmohammadi F, Barangi S, Aghaee-Bakhtiari SH et al (2023) Melatonin ameliorates arsenic-induced cardiotoxicity through the regulation of the Sirt1\/Nrf2 pathway in rats. BioFactors 49:620\u2013635. https:\/\/doi.org\/10.1002\/BIOF.1934","journal-title":"BioFactors"},{"key":"3718_CR83","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/FNMOL.2020.00096","volume":"13","author":"T Ali","year":"2020","unstructured":"Ali T, Hao Q, Ullah N et al (2020) Melatonin act as an antidepressant via attenuation of neuroinflammation by targeting Sirt1\/Nrf2\/HO-1 signaling. Front Mol Neurosci 13:96. https:\/\/doi.org\/10.3389\/FNMOL.2020.00096","journal-title":"Front Mol Neurosci"},{"key":"3718_CR84","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/J.BBADIS.2013.12.011","volume":"1842","author":"L Gan","year":"2014","unstructured":"Gan L, Johnson JA (2014) Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. Biochim Biophys Acta 1842:1208\u20131218. https:\/\/doi.org\/10.1016\/J.BBADIS.2013.12.011","journal-title":"Biochim Biophys Acta"},{"key":"3718_CR85","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/J.TIV.2019.03.007","volume":"57","author":"TC Hauschild","year":"2019","unstructured":"Hauschild TC, Guerreiro G, Mescka CP et al (2019) DNA damage induced by alloisoleucine and other metabolites in maple syrup urine disease and protective effect of l-carnitine. Toxicol in Vitro 57:194\u2013202. https:\/\/doi.org\/10.1016\/J.TIV.2019.03.007","journal-title":"Toxicol in Vitro"},{"key":"3718_CR86","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/J.GENE.2014.07.051","volume":"548","author":"CP Mescka","year":"2014","unstructured":"Mescka CP, Wayhs CAY, Guerreiro G et al (2014) Prevention of DNA damage by l-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro. Gene 548:294\u2013298. https:\/\/doi.org\/10.1016\/J.GENE.2014.07.051","journal-title":"Gene"},{"key":"3718_CR87","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/J.CEB.2015.02.004","volume":"32","author":"EM Hol","year":"2015","unstructured":"Hol EM, Pekny M (2015) Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol 32:121\u2013130. https:\/\/doi.org\/10.1016\/J.CEB.2015.02.004","journal-title":"Curr Opin Cell Biol"},{"key":"3718_CR88","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1152\/PHYSREV.00041.2013","volume":"94","author":"M Pekny","year":"2014","unstructured":"Pekny M, Pekna M (2014) Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev 94:1077\u20131098. https:\/\/doi.org\/10.1152\/PHYSREV.00041.2013","journal-title":"Physiol Rev"},{"key":"3718_CR89","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1016\/J.FEBSLET.2015.09.010","volume":"589","author":"S Olivera-Bravo","year":"2015","unstructured":"Olivera-Bravo S, Barbeito L (2015) A role of astrocytes in mediating postnatal neurodegeneration in glutaric acidemia-type 1. FEBS Lett 589:3492\u20133497. https:\/\/doi.org\/10.1016\/J.FEBSLET.2015.09.010","journal-title":"FEBS Lett"},{"key":"3718_CR90","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin C, Galea E, Lakatos A et al (2021) Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci 24:312\u2013325. https:\/\/doi.org\/10.1038\/s41593-020-00783-4","journal-title":"Nat Neurosci"},{"key":"3718_CR91","doi-asserted-by":"publisher","first-page":"835597","DOI":"10.3389\/FNEUR.2022.835597","volume":"13","author":"D Janigro","year":"2022","unstructured":"Janigro D, Mondello S, Posti JP, Unden J (2022) GFAP and S100B: what you always wanted to know and never dared to ask. Front Neurol 13:835597. https:\/\/doi.org\/10.3389\/FNEUR.2022.835597","journal-title":"Front Neurol"},{"key":"3718_CR92","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/J.BBAMEM.2010.12.016","volume":"1808","author":"JM Boggs","year":"2011","unstructured":"Boggs JM, Rangaraj G, Heng YM et al (2011) Myelin basic protein binds microtubules to a membrane surface and to actin filaments in vitro: effect of phosphorylation and deimination. Biochim Biophys Acta 1808:761\u2013773. https:\/\/doi.org\/10.1016\/J.BBAMEM.2010.12.016","journal-title":"Biochim Biophys Acta"},{"key":"3718_CR93","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/JNC.12195","volume":"125","author":"G Harauz","year":"2013","unstructured":"Harauz G, Boggs JM (2013) Myelin management by the 18.5-kDa and 21.5-kDa classic myelin basic protein isoforms. J Neurochem 125:334\u2013361. https:\/\/doi.org\/10.1111\/JNC.12195","journal-title":"J Neurochem"},{"key":"3718_CR94","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1083\/JCB.200411047","volume":"170","author":"J Lee","year":"2005","unstructured":"Lee J, Gravel M, Zhang R et al (2005) Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J Cell Biol 170:661\u2013673. https:\/\/doi.org\/10.1083\/JCB.200411047","journal-title":"J Cell Biol"},{"key":"3718_CR95","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1042\/AN20090051","volume":"2","author":"D Fulton","year":"2010","unstructured":"Fulton D, Paez PM, Campagnoni AT (2010) The multiple roles of myelin protein genes during the development of the oligodendrocyte. ASN Neuro 2:25\u201337. https:\/\/doi.org\/10.1042\/AN20090051","journal-title":"ASN Neuro"},{"key":"3718_CR96","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0022-510X(72)90121-9","volume":"15","author":"JJ Martin","year":"1972","unstructured":"Martin JJ, Schlote W (1972) Central nervous system lesions in disorders of amino-acid metabolism: a neuropathological study. J Neurol Sci 15:49\u201376. https:\/\/doi.org\/10.1016\/0022-510X(72)90121-9","journal-title":"J Neurol Sci"},{"key":"3718_CR97","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0022-3476(65)80122-6","volume":"66","author":"JH Menkes","year":"1965","unstructured":"Menkes JH, Philippart M, Fiol RE (1965) Cerebral lipids in maple syrup disease. J Pediatr 66:584\u2013594. https:\/\/doi.org\/10.1016\/S0022-3476(65)80122-6","journal-title":"J Pediatr"},{"key":"3718_CR98","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/PATH.1700810209","volume":"81","author":"L Crome","year":"1961","unstructured":"Crome L, Dutton G, Ross CF (1961) Maple syrup urine disease. J Pathol Bacteriol 81:379\u2013384. https:\/\/doi.org\/10.1002\/PATH.1700810209","journal-title":"J Pathol Bacteriol"},{"key":"3718_CR99","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/ARCHNEUR.1961.00450160001001","volume":"5","author":"J Silberman","year":"1961","unstructured":"Silberman J, Dancis J, Feigin I (1961) Neuropathological observations in maple syrup urine disease: branched-chain ketoaciduria. Arch Neurol 5:351\u2013363. https:\/\/doi.org\/10.1001\/ARCHNEUR.1961.00450160001001","journal-title":"Arch Neurol"},{"key":"3718_CR100","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0887-8994(92)90038-Z","volume":"8","author":"A Kamei","year":"1992","unstructured":"Kamei A, Takashima S, Chan F, Becker LE (1992) Abnormal dendritic development in maple syrup urine disease. Pediatr Neurol 8:145\u2013147. https:\/\/doi.org\/10.1016\/0887-8994(92)90038-Z","journal-title":"Pediatr Neurol"},{"key":"3718_CR101","doi-asserted-by":"publisher","first-page":"963520","DOI":"10.1155\/2013\/963520","volume":"2013","author":"A Popa-Wagner","year":"2013","unstructured":"Popa-Wagner A, Mitran S, Sivanesan S et al (2013) ROS and brain diseases: the good, the bad, and the ugly. Oxidative Med Cell Longev 2013:963520. https:\/\/doi.org\/10.1155\/2013\/963520","journal-title":"Oxidative Med Cell Longev"},{"key":"3718_CR102","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1007\/S12035-015-9313-0","volume":"53","author":"L Rosa","year":"2016","unstructured":"Rosa L, Galant LS, Dall\u2019Igna DM et al (2016) Cerebral oedema, blood\u2013brain barrier breakdown and the decrease in Na+,K+-ATPase activity in the cerebral cortex and hippocampus are prevented by dexamethasone in an animal model of maple syrup urine disease. Mol Neurobiol 53:3714\u20133723. https:\/\/doi.org\/10.1007\/S12035-015-9313-0","journal-title":"Mol Neurobiol"},{"key":"3718_CR103","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/J.IJDEVNEU.2019.07.007","volume":"78","author":"LB Wessler","year":"2019","unstructured":"Wessler LB, de Miranda RV, Bittencourt Pasquali MA et al (2019) Administration of branched-chain amino acids increases the susceptibility to lipopolysaccharide-induced inflammation in young Wistar rats. Int J Dev Neurosci 78:210\u2013214. https:\/\/doi.org\/10.1016\/J.IJDEVNEU.2019.07.007","journal-title":"Int J Dev Neurosci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03718-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03718-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03718-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T05:23:28Z","timestamp":1713936208000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03718-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":103,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["3718"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03718-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]},"assertion":[{"value":"27 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental procedures of this study were approved by the Ethical Committee of UFRGS (n<sup>o<\/sup> 42875) and performed according to the Guide for the Care and Use of Laboratory Animals (Eighth edition, 2011).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}